Massivemarkets

Nasdaq: LYCA · Listed Oct 23, 2026

Lycia Therapeutics IPO

$31.35

▲ +1.39%today · +74.17% since the $18.00 IPO price

15-minute delayed · as of 7:30:02 PM EST on Nov 18, 2026

Lycia Therapeutics (LYCA) priced its IPO at $18.00 a share and has traded on Nasdaq since Oct 23, 2026.

Last session · Nov 18, 2026

VWAP 31.30open 30.60high 32.47$31.50volume · rising bars above the line, falling bars below29.29K9:304:00
Market cap
$1.63B
from the ticker reference
Volume
350.73K
shares, regular session
VWAP
$31.30
the last price is +0.15% from the volume-weighted average
Day range
30.45–32.85
low to high

The trading numbers are from the last session, Nov 18, 2026.

The debut race

LYCA against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%LYCA +74.97%

The IPO scoreboard

LYCA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

LYCA against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Lycia Therapeutics '26$317.52M+58.61%+64.22%+52.56%Not yet
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Lycia Therapeutics IPO offers 17.64M shares to raise $317.52M, before any underwriters' option.

$14$16$17$18$20
Expected price range
$16 to $18
IPO price
$18.00
Shares offered
17.64M
Money raised
$317.52M
Listing date
Oct 23, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Lycia Therapeutics$317.52M

Where LYCA ranks

Lycia Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • LYCA$1.63B

What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

  1. Oct 23, 2026

    First trade

    Prices, bars, and snapshots

  2. Oct 28, 2026 · est.

    Options list

    Option chain and open interest

  3. Nov 12, 2026 · est.

    First short interest

    Short interest and daily short volume

  4. Nov 17, 2026 · est.

    Quiet period ends

    Analyst ratings and price targets

  5. Feb 14, 2027

    First 13F deadline

    Which funds hold the stock

  6. Date not set

    First earnings

    Income statement and ratios

  7. Apr 20, 2027 · est.

    Lock-up expires

    Insider sales on Form 4

Filings and the company

What Lycia Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Lycia Therapeutics discloses to the SEC on Form 8-K.

  • Charter amendmentOct 26, 2026

    On October 26, 2026, Lycia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware ... in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.

About Lycia Therapeutics

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

Ticker
LYCA
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Listed
Oct 23, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Lycia Therapeutics IPO price?

$18.00 a share.

When did Lycia Therapeutics go public?

Lycia Therapeutics listed on Nasdaq on Oct 23, 2026 under the ticker LYCA.

How much did the Lycia Therapeutics IPO raise?

$317.52M, before any underwriters' option.

How did Lycia Therapeutics open on its first day?

LYCA first traded at $28.55, +58.61% from the IPO price of $18.00.

How did LYCA close on its first day?

Its last regular-session trade was $29.56, +64.22% from the IPO price of $18.00.

What was the LYCA first-day trading range?

$22.19 to $36.49 in the regular session.

How many LYCA shares traded on the first day?

2.21M shares in the regular session.

How many shares did Lycia Therapeutics sell in its IPO?

17.64M shares.

What exchange is LYCA listed on?

Lycia Therapeutics lists on Nasdaq under the ticker LYCA.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the LYCA data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/LYCA/range/5/minute
Market cap/v3/reference/tickers/LYCA
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.